Early experience with the valve-in-valve technique in the treatment of failed bioprosthetic surgical valves in transcatheter aortic valve replacement (TAVR) has yielded acceptable acute procedural results. This turned the technique into another therapeutic option, one that could even cause the reassessment of the age limit for the surgical implantation of a mechanical or bioprosthesis valve....
See the Presentations of the 2016 Chile Sessions
We thank all the speakers of the Chile 2016 Sessions who shared their presentations to contribute to our mission of promoting the dissemination of information from research and clinical practice in Interventional Cardiology. You can read and/or download them below Lluberas, Ricardo. “Role of pharmacovasive therapy in the treatment of IAMcEST. Implications for Latin...
TAVR in Pure Aortic Insufficiency: Yes or No?
Courtesy of Dr. Agustín Vecchia. Surgery is the treatment of choice for patients with symptomatic aortic insufficiency and/or ventricular dilatation or decreased ventricular function. The broad implementation of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis, the emergence of new devices, and the experience acquired by operators have brought this treatment to off-label indications such...
Transcatheter Tricuspid Valve in valve
Original Title: Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valve. An International, Multicenter Registry Study. Reference: Doff B. McElhinney, et al. Circulation 2016;133:1582-93 Courtesy of Dr. Carlos Fava. Transcatheter tricuspid valve in valve implantation (TVIV) is infrequent, complex and biological valves last from 10 to 15 years. Reoperation is associated with high...
Bons resultados nos procedimentos de implante transcateter valva-em-valva mitral e valva-em-anel mitral
Fundamentos: Válvulas bioprotéticas são cada vez mais implantadas em cirurgias cardíacas abertas. Estas válvulas geralmente falham, resultando na necessidade de uma nova cirurgia cardíaca, com risco elevado de mortalidade. O implante transcateter valva-em-valva mitral (VIVM) pode eliminar a necessidade de reoperação. A implantação transcateter valva-em-valva e valva-em-anel mitral (VIAM) é uma abordagem menos invasiva e,...
Exclusive Interview with Dr. Henrique Ribeiro on his article: coronary obstruction after TAVI
Recentemente uma revisão e metanálise sobre obstrução coronária após o implante de TAVI foi publicada na revista JAAC. Este artigo foi motivo de uma aula no TCT 2013 ministrada pelo Dr. Henrique Ribeiro (autor principal deste estudo). Segue abaixo o resumo do estudo e a entrevista com o dr. Henrique: Obstrução coronária pós TAVI Fundamentos...
Low flow impact on outcomes following TAVI should be taken into account
Original title: Impact of Low Flow on the Outcome of High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Reference: Florent Le Ven, et al. J Am Coll Cardiol 62;9:792-788 A study of low flow (SVi <35ml/m2) in the context of severe aortic stenosis has shown it is a predictor of worse outcomes after surgery, even though evolution with medical...